U.S. stocks experienced slight gains on Wednesday; however, investors remained on edge regarding the potential escalation of the Israel-Iran conflict.

BioNTech’s recent $1.25 billion all-stock acquisition of former rival CureVac marks a definitive shift in strategy—away from COVID-19 vaccine reliance and toward building a diversified cancer portfolio.

Amazon has begun to increase its use of artificial intelligence (AI) across key parts of its business. As a result of this shift, the company’s corporate workforce could shrink in the coming years.

U.S. stocks dived on Tuesday, showing concerns over rising tensions between Israel and Iran and growing uncertainty surrounding President Trump’s trade policies.

At a time when the S&P 500 is treading water, Palantir has outperformed virtually every major tech stock and is now trading at a sky-high 205x forward earnings and 71x forward sales.

Circle Internet Group (CRCL) has been one of the most exciting stories of the year, with its stock continuing to soar following its highly anticipated IPO earlier this month.

U.S. stocks rebounded on Monday, recovering from last week’s losses as overall investor sentiment improved following reports of a potential de-escalation in the ongoing Israel-Iran conflict.